The final maturation of the prefrontal cortex (PFC) continues into early adulthood and is delayed compared with other forebrain structures. However, how these late onset changes in the PFC relate to neurodevelopment disorders is poorly understood. Fragile X syndrome (FXS) is a prevalent neurogenetic disorder linked to deficits in PFC function. mGlu 5 is an important molecular hub in the etiology of FXS. Thus we have examined changes in mGlu 5 function in the PFC in a mouse model of FXS (Fmr1 knockout) during early adulthood and subsequent maturity. An unusual endophenotype was identified; during early adulthood (2-month-old) Fmr1 knockout mice show a severe deficit in mGlu 5 dependent eCB synaptic plasticity; however, in 1-year-old this deficit self rectifies. This adulthood onset correction in mGlu 5 function is linked to an engagement of TRPV1 receptors in 1-year-old mice. In 2-month-old Fmr1 knockout mice, mGlu 5 mediated synaptic plasticity could be recovered with eCB system targeted drugs, but also by direct enhancement of mGlu 5 function with a positive allosteric modulator. These results point to further refinements to the role of mGlu 5 in FXS. Furthermore our findings suggest when studying neurodevelopmental disorders with a significant PFC phenotype consideration of late onset changes may be important.
Introduction
Fragile X syndrome (FXS) is a common heritable X-linked developmental disorder, leading to intellectual disability and behavioral difficulties frequently meeting the criteria for autism diagnosis. Indicators of cognitive impairment in FXS are often apparent from early childhood along with other neurological dysfunctions such as deficits in attention and anxiety. Study of the cognitive impairments suggests executive function is most profoundly affected in FXS individuals, particularly that of inhibitory control. Consequently skills that require attention control such as working memory and cognitive flexibility are particularly impacted (Cornish et al. 2001 ; Van der Molen et al. 2010; Huddleston et al. 2014) . A point of contention is whether a further relative decline in cognitive function occurs after early childhood. Longitudinal studies of IQ suggest that during late childhood and early adulthood there is a relative decline in IQ in FXS males (Lachiewicz et al. 1987; Hagerman et al. 1989; Hodapp et al. 1990; Wright-Talamante et al. 1996) ; however, there may be confounding factors (Hay 1994; Huddleston et al. 2014) . Nevertheless FXS individuals are capable of increasingly complex behavioral learning and adaptations that can be developed well into adulthood; furthermore some comorbid autism linked behaviors often show late improvement (Bailey et al. 2009; McDuffie et al. 2010; Thurman et al. 2015) . Either way the FXS endophenotype shows age-linked variations and individuals can expect lifespan changes in FXS symptomology.
Although FXS is due to the genetic silencing of a single gene (FMR1), the underlying physiology is complex. A particularly strongly impacted structure is the central synapse. FXS individuals and the Fmr1 knockout (Fmr1 KO) mouse model of FXS show alterations in both synaptic morphology and function. Both inhibitory and excitatory neurotransmission are affected and mechanisms of neuromodulation are often altered (Sidorov et al. 2013) . Notably Fmr1 KO mice show a clinically relevant enhancement of mGlu 5 neuromodulatory signaling that affects both the physiology and behavior of these animals .
The cognitive deficits and behavioral abnormalities in FXS suggest that the prefrontal cortex may be particularly affected. In rodents the medial prefrontal cortex (mPFC) serves a roughly equivalent neurological role and mPFC associated behaviors in the Fmr1 KO mouse are affected (McNaughton et al. 2008; Gantois et al. 2013; Kramvis et al. 2013; Gross et al. 2015) . Correspondingly the physiology of principal neurons in the mPFC are altered in the Fmr1 KO and there is strong evidence that synaptic gain function is negatively affected Kalmbach et al. 2015; Koga et al. 2015) . Specifically NMDA receptor mediated long-term potentiation of excitatory neurotransmission shows deficits across the mPFC (Zhao et al. 2005; Meredith et al. 2007; Chen et al. 2014; Martin et al. 2016 ). mGlu 5 is strongly expressed in the mPFC, however, whether there are FXS linked changes in mGlu 5 function in the mPFC is unclear Since a great deal of evidence suggest mGlu 5 is central to the pathophysiology and potential therapeutics in FXS, a better understanding of mGlu 5 synaptic function in the mPFC is imperative.
Glutamatergic synapses on layer 5 principal neurons in the adult mPFC respond to mGlu 5 mediated synaptic plasticity. Either pharmacological or stimulus mediated activation of mGlu 5 leads to a prolonged depression in glutamatergic neurotransmission due to an endocannabinoid (eCB) dependent decrease in presynaptic vesicular release (Lafourcade et al. 2007 ). This eCB mediated long-term depression (eCB-LTD) is important for normal mPFC function, and its absence is associated with mPFC malfunction in several neuropsychiatric disorders Kasanetz et al. 2013; Lovelace et al. 2014; Thomazeau et al. 2014 ). Thus we have examined mGlu 5 mediated eCB-LTD in Fmr1 KO mice during early adulthood (2 months) and later life (12 months), reflecting the delayed maturation of the mPFC and the possible lifespan changes found in FXS. We report that eCB-LTD is compromised in Fmr1 KO mice, but that during adulthood alternative mechanisms result in a recovery of mGlu 5 mediated LTD in 12-month-old mice. Furthermore, pharmacological enhancements of either eCB signaling or mGlu5 function are able to compensate for the loss of eCB-LTD in 2-month-old Fmr1 KO mice.
Materials and Methods
Animals were treated in compliance with the European Communities Council Directive (86/609/EEC) and the United States National Institutes of Health Guide for the Care and Use of Laboratory Animals. All mice were group housed with 12 h light/ dark cycles. Male Fmr1 KO2 mice, null for protein and mRNA on a C57Bl6/J genetic background were used, with interleaved wildtype littermates as a control group. 2-Month-old mice were 70 ± 10 days and 1-year-old mice were 12-15 months in age.
Slice Preparation
Mice were anesthetized with isoflurane and decapitated according to institutional regulations. The brain was sliced (300 µm) in the coronal plane with a vibratome (Integraslice, Campden Instruments, Loughborough, UK) in a sucrose-based solution at 4°C (in mM: 87 NaCl, 75 sucrose, 25 glucose, 5 KCl, 21 MgCl 2 , 0.5 CaCl 2 , and 1.25 NaH 2 PO 4 ). Slices were allowed to recover for 60 min at 32-35°C in artificial cerebrospinal fluid (aCSF) containing 126 mM NaCl, 2.5 mM KCl, 2.4 mM MgCl 2 , 1.2 mM CaCl 2 , 18 mM NaHCO 3 , 1.2 mM NaH 2 PO 4 , and 11 mM glucose, equilibrated with 95% O 2 /5% CO 2 . Slices were then maintained at 22 ± 2°C until recording.
Electrophysiology
Whole-cell patch-clamp and extracellular field recordings were made from layer 5 pyramidal cells in the prelimbic mPFC. Glass recording electrodes were placed in the medial portion of the visually identified layer 5/6 (typically 400 µm from the midline) and slices superfused (2 ml/min) with warmed aCSF giving a bath temperature of 32°C. The recording aCSF contained picrotoxin (100 µM) prepared in DMSO (final aCSF concentration: 0.1%) to block GABA A receptors. To evoke synaptic currents, 150-200 µs stimuli were delivered at 0.1 Hz through an aCSFfilled glass electrode positioned dorsal to the recording electrode in the visually identified layer 3/5 boundary. eCB-LTD was induced with a 10 Hz 10 min stimulation protocol delivered with the same power as baseline through the glass stimulation electrode. For extracellular field experiments, the recording pipette was filled with aCSF. The glutamatergic nature of the field excitatory postsynaptic potential (fEPSP) was confirmed at the end of the experiments using the ionotropic glutamate receptor antagonist 6,7-dinitroquinoxaline-2,3-dione (DNQX, 20 µM), that specifically blocked the synaptic component without altering the nonsynaptic component (Pennartz et al. 1990) .
For whole-cell patch-clamp recordings, pyramidal neurons in mPFC layer 5 were visualized using an infrared microscope (BX-50, Olympus). Experiments were made with electrodes containing 145 mM potassium gluconate, with 5 mM NaCl, 1 mM MgCl 2 , 1 mM EGTA, 0.3 mM CaCl 2 , 2 mM Na 2+ -ATP, 0.3 mM Na + -GTP, 10 mM glucose buffered with 10 mM HEPES, pH 7.3, osmolarity 290 mOsm. Electrode resistances were typically 3-6 MOhm. For patch-clamp experiments the pipette capacitance was compensated and the reference potential of the amplifier was adjusted to zero before breaking into the cell or entering the slice for field EPSP experiments. Junction potentials were not corrected. Experiments were discontinued if either input resistance or access resistance deviated by more than 20%. Spontaneous EPSCs (spEPSC) were recorded in the voltage-clamp configuration at −70 mV.
Data Acquisition and Analysis
Data were recorded on a MultiClamp700B (Axon Instruments), filtered at 2 or 10 kHz (spike characterization), digitized (10 or 50 kHz, DigiData 1440 A, Axon Instrument), collected using Clampex 10.2 and analyzed using Clampfit 10.2 (all from Molecular Device, Sunnyvale, USA). Analysis of both area and amplitude of fEPSPs was performed. The magnitude of LTD was calculated 35-40 min after challenge. LTD data were collated and analyzed from throughout the lifetime of the project, except during experimental treatments where subsets of partially interleaved control experiments were analyzed. spEPSCs were analyzed with Axograph X (Axograph) by passing a variable amplitude prototypical AMPAR event (τ rise = 0.5 ms, τ decay = 3 ms; 10 ms window; noise threshold: −3) over the recording. Statistical analysis of data was performed with GraphPad Prism (GraphPad Software Inc., La Jolla, CA, USA) using tests indicated in the main text after outlier subtraction (Grubbs' method). 
Results
Adulthood Onset Changes in mGlu 5 Mediated eCB-LTD in Fmr1 KO Mouse mPFC Previous studies have shown that trains of 10 Hz synaptic stimulation activate mGlu 5 receptors leading to eCB-LTD in multiple brain areas (Robbe et al. 2002; Lafourcade et al. 2007; Puente et al. 2011) . Using the same stimulation protocol eCB-LTD was induced in layer 5 of 2-month-old Fmr1 KO mice and wildtype littermates. In wildtype mice 10 Hz stimulation resulted in a robust and prolonged depression of fEPSPs (Fig. 1A) . However, in Fmr1 KO mice eCB-LTD stimulation trains failed to produce a prolonged depression of fEPSPs (fEPSP percent of baseline; WT: 78.8 ± 3.0%, n = 18; Fmr1 KO: 106.5 ± 3.6%, n = 28). eCB-LTD was analyzed by comparing fEPSP amplitudes before and 40 min after 10 Hz stimulation train in wildtype and Fmr1 KO mice. In 2-month-old mice there was a highly significant interaction between the stimulation protocol and genotype [F(1,35) = 12.9, P = 0.001; two-way repeat measure (RM) ANOVA], responses were significantly different from baseline in wildtype mice, but not Fmr1 KO mice (P < 0.01; Holm-Sidak multiple comparisons test).
During aging layer 5 mPFC neurons from Fmr1 KO mice show a progressive decline in NMDA receptor mediated LTP (Martin et al. 2016) , we asked if there may be an equivalent change in eCB-LTD. Using the same stimulation protocol, fEPSPs were recorded from 1-year-old Fmr1 KO mice and their wildtype littermates (Fig. 1B) . In contrast to 2-month-old mice, both wildtype and Fmr1 KO mice expressed eCB-LTD at this age (WT: 83.4 ± 5.3%, n = 7; Fmr1 KO: 81.0 ± 4.1%, n = 9). In 1-yearold mice there was not a significant interaction between LTD and genotype [F(1,18) = 0.14, P = 0.70; two-way RM ANOVA] and both wildtype and Fmr1 KO mice responses were significantly depressed in response to stimulation (P < 0.01, Holm-Sidak MC). Thus in the older Fmr1 KO mPFC there is a surprising recovery of eCB-LTD that is absent in 2-month-old mice.
To confirm the stimulus evoked eCB-LTD results, experiments were repeated by directly activating mGlu 5 with the selective agonist (S)-DHPG. 2-month-old Fmr1 KO and wildtype neurons were challenged with 50 µM DHPG for 10 min followed by a period of washout (Fig. 1C) . In both Fmr1 KO and wildtype neurons DHPG induced an equivalent acute depression of fEPSPs, which in wildtype was followed by a sustained depression of responses (WT: 80.8 ± 3.4% of baseline, n = 14). In contrast Fmr1 KO responses returned to baseline values after washout (Fmr1 KO: 98.1 ± 6.4% of baseline, n = 9). Comparing the fEPSP amplitudes before and 40 min after DHPG challenge in 2-month-old mice a significant interaction between genotype and DHPG was found [F(1,16) = 9.6, P = 0.007; two-way RM ANOVA], responses were significantly different from baseline in wildtype mice, but not Fmr1 KO mic (P < 0.01; Holm-Sidak MC). Experiments were repeated in 1-year-old mPFC neurons Scale bar: 10 ms, 0.1 mV; *P < 0.05, **P < 0.01. using an identical DHPG protocol (Fig. 1D ). Again DHPG resulted in a large transient depression of fEPSPs, however, after washout of DHPG both wildtype and Fmr1 KO responses remained depressed (fEPSP percent of baseline; WT: 71.7 ± 5.5%, n = 8; Fmr1 KO: 79.7 ± 4.4%, n = 9). Response amplitudes were analyzed before and 40 min after DHPG induced LTD and no significant interaction between genotype and stimulation was identified [F(1,15) = 0.397, P = 0.538; two-way RM ANOVA]. fEPSPs from both wildtype and Fmr1 KO 12-month-old neurons were significantly depressed after DHPG challenge (WT: P < 0.01; Fmr1 KO: P < 0.01; Holm-Sidak MC). In contrast when we repeated experiments with the selective mGlu 2/3 agonist LY-379,268, LTD was identical in both genotypes in 2-monthold and 1-year-old mice ( Supplementary Fig. 1 ).
1-Year-Old Fmr1 KO Mice Reacquire mGlu 5 LTD Via a Distinct Mechanism
The mPFC eCB-LTD experiments suggest an unusual aging linked endophenotype exists at layer 5 Fmr1 KO synapses. In young adult mice (2-month-old) mGlu 5 eCB-LTD is absent; however, during aging mGlu 5 eCB-LTD is apparently recovered, such that 1-year-old Fmr1 KO mice express a robust LTD similar to wildtype mice. To better understand this puzzling recovery of eCB-LTD in 1-year-old Fmr1 KO mice, we pursued a pharmacologically characterization of the underlying mechanisms. In young adult mice eCB-LTD involves the retrograde activation of presynaptic CB 1 receptors by the eCB molecule 2-arachidonolyglycerol (2-AG) and is thus blocked with CB 1 receptor antagonists ( Supplementary Fig. 2 ). Whether a similar mechanism is responsible for eCB-LTD in older mice is uncertain, therefore we first confirmed a CB 1 receptor dependency in 1-year-old wildtype mice and Fmr1 KO littermates. mPFC neurons from 1-year-old mice were pretreated with the CB 1 receptor antagonist AM251 (4 µM) and then challenged with eCB-LTD stimulation protocol ( Fig. 2A) . AM251 blocked the sustained depression of fEPSPs due to eCB-LTD stimulation protocol in 1-year-old wildtype neurons without affecting the initial post stimulus train depression of responses, confirming engagement of a similar eCB-LTD mechanism in younger and older wildtype mice. However, in recordings from Fmr1 KO mice AM251 was surprisingly ineffective at blocking eCB-LTD. Responses 40 minutes after the stimulation protocol were depressed in AM251 treated Fmr1 KO neurons (fEPSP percent of baseline; WT (AM251): 100.4 ± 3.2%, n = 8; Fmr1 KO(AM251): 83.0 ± 2.8%, n = 8). fEPSP responses were compared before and 40 after stimulation protocol in naïve and AM251 treated 1-year-old Fmr1 KO experiments (Fig. 2B) , however, there was no interaction between drug treatment and induction of eCB-LTD [F(1,17) = 0.93, P = 0.348; two-way RM ANOVA]. Instead fEPSP recordings were significantly depressed in both naïve and AM251 treated mPFC neurons after stimulation protocol (P < 0.01, Holm-Sidak MC). Finally the percent LTD was compared across groups 40 minutes after induction of eCB-LTD (Fig. 2C) . Blocking CB 1 receptors significantly affected LTD [F(3,29) = 6.64, P = 0.002, one-way ANOVA], due to a block of eCB-LTD in 1-year-old wildtype neurons (P < 0.01, Holm-Sidak MC). LTD in 1-year-old Fmr1 KO neurons treated with AM251 was not significantly different from controls. Thus the reestablishment of nominally eCB-LTD in the 1-year-old Fmr1 KO mPFC is not due to a direct recovery of CB 1 receptor mediated LTD, but a mechanistically distinct process.
Previous work has identified changes in NMDA receptor physiology in the mPFC of Fmr1 KO mice Martin et al. 2016) . Thus the recovery in stimulus evoked LTD might be due to an engagement of NMDA receptor mediated mechanisms in 1-year-old Fmr1 KO neurons. Stimulus evoked eCB-LTD was repeated in 1-year-old Fmr1 KO mPFC in the presence of the NMDA receptor antagonist D-AP5 (50 µM) to test for any NMDA receptor dependence ( Supplementary Fig. 3 ). However the time course and magnitude of LTD was similar in naïve and D-AP5 treated neurons mPFC [fEPSP percent of baseline; Fmr1 KO (naïve): 81.9 ± 7.3%, n = 5; Fmr1 KO (AP5): 76.3 ± 5.2%, n = 6]. This suggests that NMDA receptors are not responsible for the aging linked recovery of eCB-LTD.
To confirm that stimulus evoked eCB-LTD still engages an mGlu 5 activated mechanism, 1-year-old Fmr1 KO mice experiments were repeated in the presence of the selective mGlu 5 antagonist MPEP. mPFC neurons were pretreated with 10 µM MPEP before challenge with a 10 Hz stimulation train (Fig. 3A) . fEPSPs from both wildtype and Fmr1 KO neurons showed an acute depression, however responses returned to baseline values in the subsequent recovery period [fEPSP percent baseline; WT (MPEP): 103.6 ± 7.8%, n = 8; Fmr1 KO (MPEP): 99.1 ± 6.0%, n = 5]. No significant interaction was found quantifying fEPSP amplitudes before and 40 min after eCB-LTD protocol between MPEP treated wildtype and Fmr1 KO neurons [F (1,10) = 0.02, P = 0.90, two-way RM ANOVA; Fig. 3B ], furthermore there was no LTD main effect (P = 0.15) indicating a block of LTD with mGlu 5 inhibition. This is apparent when the percent LTD is compared between naïve and MPEP treated neurons (Fig. 3C) , which is significantly altered [F(3,25) = 6.08, P = 0.003, one-way ANOVA]. The expression of LTD is affected in both wildtype and Fmr1 KO MPEP treated neurons compared with controls (WT: P < 0.01; Fmr1: P < 0.05, Fisher's LSD test). Thus in concord with DHPG induced eCB-LTD in 1-year-old neurons an underlying mGlu 5 process is involved.
Although most evidence points to CB 1 receptor mediated LTD as the mechanistically dominant form of eCB-LTD in the CNS, recent reports have identified an important TRPV1 mediated LTD at a set of central synapses (Castillo et al. 2012) . TRPV1 receptors are nonselective cation channels activated by eCBs and therefore might be important in eCB-LTD in 1-yearold Fmr1 KO neurons. Using the archetypal TRPV1 antagonist capsazepine (CPZ), neurons were pretreated with 10 µM CPZ and challenged with eCB-LTD stimulation protocol (Fig 3D) . Surprisingly, fEPSP responses from both 1-year-old Fmr1 KO mice and wildtype littermates returned to baseline in the presence of TRPV1 antagonist [fEPSP percent baseline; WT (CPZ): 96.1 ± 4.7%, n = 4.7; Fmr1 KO(CPZ): 103.9 ± 10.7%, n = 5]. To confirm the unexpected inhibition of eCB-LTD, experiments were repeated with the unrelated TRPV1 antagonist AMG9810 (Fig 3E) . Again pretreatment in both wildtype and Fmr1 KO mPFC neurons with 10 µM AMG9810 resulted in fEPSPs returning to baseline 40 min after eCB-LTD stimulation protocol [fEPSP percent baseline; WT(AMG9810): 100.2 ± 5.8%, n = 8; Fmr1 KO(AMG9810): 99.2 ± 6.8%, n = 4]. Results were analyzed by comparing the percent LTD 40 minutes after stimulation protocol (Fig. 3E) and indicated a significant effect was present [F(5,30) = 3.42, P = 0.015, one-way ANOVA]. In all cases 1-year-old Fmr1 KO and wildtype neurons treated with TRPV1 antagonists resulted in a significant inhibition of eCB-LTD compared with control experiments (P < 0.05, Fisher's LSD test). In contrast when we repeated experiments in 2-monthold wildtype neurons with TRPV1 antagonists, we failed to observe an inhibition of eCB-LTD ( Supplementary Fig. 4 ). Thus the restoration of mPFC mGlu 5 eCB-LTD in 1-year-old Fmr1 KO mice owes its recovery to an alternative TRPV1 mediated mechanism, which also has a role in wildtype eCB-LTD in late adulthood.
Loss of mGlu 5 LTD in 2-Month-Old Fmr1 KO Mice is Linked to a Deficit in 2-AG Function
To better understand the mechanisms responsible for the absence of eCB-LTD in younger 2-month-old Fmr1 KO mice, the glutamatergic synapses from layer 5 neurons were characterized. First input-output curves were generated from mPFC fEPSPs in Fmr1 KO and wildtype littermates in response to building synaptic stimulation (Fig. 4A ). Responses were similar in both genotypes, suggesting no gross changes. Layer 5 mPFC principal neurons show significant spontaneous activity during reduced GABAergic signaling ). Changes in this activity can indicate alterations in connectivity and synaptic strength in these neurons. Thus spontaneous EPSC (spEPSC) activity was registered at close to resting membrane potentials via patch-clamp recording in Fmr1 KO neurons and the amplitude and the interval between events quantified (Fig. 4) . The mean spEPSC interval between groups was not significantly different in the 2-month-old mice [Mean interval; WT: 0.104 ± 0.014 s, n = 19; Fmr1 KO: 0.129 ± 0.025 s, n = 12; P = 0.36, t(29) = 0.93] and the distribution of event intervals, plotted as cumulative distribution function, was similar (Fig. 4B) . Likewise the mean spEPSC amplitude was nearly identical in Fmr1 KO and wildtype littermates [Mean amplitude; WT: 17.6 ± 0.9 pA, n = 19; Fmr1 KO: 17.7 ± 1.0 pA, n = 11; P = 0.93, t(28) = 0.09] and the distribution of individual spEPSC amplitudes was likewise similar in both groups (Fig. 4C) . Differences in cortical network activity have been reported in Fmr1 KO mice which may contribute to in vitro spEPSC recordings, therefore recordings were repeated in the presence of tetrodotoxin (1 µM) and miniature EPSCs (mEPSP) quantified (Supplementary Fig. 5 ). The mean mEPSC amplitudes [WT: 13.3 ± 0.9 pA, n = 7; Fmr1 KO: 14.0 ± 0.6 pA, n = 7; P = 0.57, t(12) = 0.58] and the mean intervals between mEPSC events [WT: 0.108 ± 0.012 s, n = 7; Fmr1 KO: 0.107 ± 0.009 s, n = 7; P = 0.91, t(12) = 0.10] were again similar in Fmr1 KO and wildtype neurons. Thus basal synaptic activity is conserved in 2-month-old neurons in the Fmr1 KO mPFC and is unlikely linked to the deficits in eCB-LTD.
Principal neurons in layer 5 of the mPFC may be subdivided into 2 broad pyramidal neuron populations based on their morphology and axonal projections: an intratelencephalic projecting (IT) group and a pons/thalamic projecting (pyramidal tract, PT) group (Dembrow et al. 2010; Gee et al. 2012) . Importantly recent studies have identified subpopulation specific changes in intrinsic properties in Fmr1 KO mice (Kalmbach et al. 2015) . These 2 neuronal populations receive distinct synaptic inputs, thus our nonselective recording of spEPSCs from layer 5 neurons may occlude subtype specific differences between wildtype and Fmr1 KO spontaneous synaptic activity. We took advantage of a prominent h-current found in PT neurons to divide our neuronal recordings into putative IT and PT populations (Supplementary Methods). The principal resting membrane properties in Fmr1 KO and wildtype neurons was not significantly different within each subpopulation (Supplementary Table 1 ). Furthermore the distribution and mean of spEPSC amplitudes and event intervals was similar in both IT and PT populations between genotypes ( Supplementary  Fig. S6 ). This suggests that subpopulation differences in layer 5 spontaneous activity are not prominent in mPFC Fmr1 KO neurons and are unlikely linked to deficits in eCB-LTD.
Changes in eCB-LTD might indicate deficits in presynaptic CB 1 receptor function at layer 5 synapses. Dose response curves measuring CB 1 receptor mediated inhibition of EPSPs were constructed with the selective agonist CP55,940 to examine CB 1 receptor function. CP55,940 was effective at inhibiting fEPSPs in both Fmr1 KO and wildtype littermates (Fig. 4D) . Standard curves we fitted to approximate EC 50 and maximal inhibition values. The EC 50 value was similar in 2-month-old Fmr1 KO and wildtype mPFC (WT: 129 nM; Fmr1 KO: 84 nM) and the maximal inhibition was not significantly different [WT: 46.1 ± 3.6%; Fmr1 KO: 50.0 ± 9.3%; P = 0.65, t(28) = 0.45]. Thus CB 1 receptor function does not appear compromised at these synapses. Recent studies have identified changes in tonic CB 1 receptor function as important in models of autism (Földy et al. 2013) . Wash on of a selective CB 1 receptor inverse agonist (AM251) has the effect of augmenting layer 5 mPFC fEPSPs (Fig. 4E) . fEPSP responses were compared before and 20 minutes after AM251 wash-on in Fmr1 KO and wildtype 2-month-old neurons (Fig. 4F) . Both genotypes showed a significant augmentation in fEPSP responses (fEPSP percent baseline; WT: 122.6 ± 3.3%, n = 23; Fmr1 KO: 111.5 ± 3.8%, n = 11) that was not significantly different [F(1,33) = 0.37, P = 0.55; two-way RM ANOVA]. Thus tonic and evoked CB 1 receptor function appears conserved at these synapses in Fmr1 KO mice. eCB-LTD is highly sensitive to disruption of local 2-AG function and loss of regulated 2-AG synthesis has been linked to a number of neuropsychiatric disorders (Jung et al. 2012; Lovelace et al. 2014; Thomazeau et al. 2014 Thomazeau et al. , 2016 . To determine if changes in 2-AG concentration might be important in the loss of eCB-LTD in 2-month-old Fmr1 KO mice the degradation of 2-AG was disrupted with the MGL inhibitor JZL 184. Under normal conditions where 2-AG concentrations are optimal JZL 184 should not affect the expression of eCB-LTD; however, in pathological states it may have a restorative function. Stimulus evoked eCB-LTD was repeated in Fmr1 KO and wildtype littermates in the presence of 1 µM JZL 184 and fEPSP responses followed for a further 40 min (Fig. 4G) . In both Fmr1 KO and wildtype neurons the addition of JZL 184 lead to a sustained depression of fEPSPs [fEPSP percent baseline; WT (JZL184): 77.8 ± 7.9%, n = 4; Fmr1 (JZL184): 79.2 ± 8.3%, n = 12]. fEPSP amplitudes were compared before and 40 min after stimulus evoked eCB-LTD in control and JZL 184 treated Fmr1 KO neurons (Fig. 4H ). There was a significant interaction between the eCB-LTD protocol and JZL 184 treatment in the Fmr1 KO mice [F(1,31) = 5.779, P = 0.022; two-way RM ANOVA] and responses were significantly different before and after stimulation in the JZL 184 treated group (P < 0.01, HolmSidak MC). To confirm an eCB mediated effect JZL 184 treatment was repeated following prior CB 1 receptor inhibition with AM251.
In the presence of AM251 and JZL 184 challenge with eCB-LTD protocol did not result in a significant change in fEPSPs [fEPSP percent baseline; Fmr1 [AM251 + JZL184]: 100.2 ± 4.2%, n = 4; P = 0.91, t paired (3) = 0.12]. Thus JZL 184 permits the induction of stimulus evoked eCB-LTD in 2-month-old Fmr1 KO layer 5 neurons. Furthermore when the percent LTD is compared across groups (Fig. 4I) , no change in eCB-LTD in wildtype neurons is seen due to JZL 184 in contrast to Fmr1 KO neurons, indicating the loss of eCB-LTD in 2-month-old Fmr1 KO mPFC is most likely due to deficits in 2-AG signaling.
Rescue of eCB-LTD in 2-Month-Old Fmr1 KO Mouse With Enhancement of mGlu 5
During stimulus evoked eCB-LTD, the local synthesis of 2-AG is the end of a signaling cascade originating from mGlu 5 activation. If deficits in 2-AG underlie the loss of eCB-LTD in 2-month-old Fmr1 KO mice, might enhancement of the mGlu 5 to 2-AG signaling cascade restore function? Targeting mGlu 5 signaling, mPFC neurons from Fmr1 KO were treated with the mGlu 5 positive allosteric modulator CDPPB (10 µM) and challenged with a stimulus evoked eCB-LTD protocol. Compared with controls, treatment with CDPPB permitted the induction of LTD in 2-month-old Fmr1 KO mice (Fig. 5A ). There was a significant interaction in the amplitude of fEPSPs before and after eCB-LTD with CDPPB (F (1,20) = 13.28, P = 0.002; two-way RM ANOVA) and responses were significantly depressed after eCB-LTD stimulation protocol in the presence of CDPPB (P < 0.01, Holm-Sidak MC). The eCB-LTD was compared in Fmr1 KO and wildtype littermates in the presence of CDPPB. Normalized fEPSPs were very similar throughout the time course of stimulus evoked eCB-LTD (Fig. 5B) . Experiments were summarized expressing eCB-LTD as a percent LTD compared with baseline (Fig. 5C ). Variation between groups was significantly different [F(3,42) = 9.72, P < 0.001; one-way ANOVA], notably multiple comparisons indicated that compared with control treatment with CDPPB resulted in a highly significant LTD in Fmr1 KO neurons (P < 0.01, Holm-Sidak MC), but that in wildtype littermates CDPPB had no significant effect on the magnitude of LTD (P = 0.82, Hom-Sidak MC). Thus enhancement of mGlu 5 function is a valid route to restoring eCB function in the Fmr1 KO mPFC.
Discussion
FXS is a neurodevelopment disorder; however, limiting study of the syndrome to the early developmental stages of the CNS ignores late changes in behavioral function found in FXS individuals. Here we have studied adulthood onset changes in mGlu 5 linked synaptic physiology in the mouse mPFC, a brain region noted for its late development and plasticity in rodents and humans. In contrast to a steady endophenotype or even a degenerative decline in function, we have identified an unexpected age-linked recovery of synaptic gain function. Specifically stimulus evoked LTD mediated by eCBs, absent in early adulthood (2-month-old), is recovered with senescence (at 1-year-old). This recovery is not due to a direct reinstatement of eCB-LTD, but instead depends on the engagement of alternative mGlu 5 coupled mechanisms. In light of these observations we show that the loss of eCB-LTD in 2-month-old neurons is tractable to pharmacotherapy, offering the possibility of restoration of synaptic gain function in the Fmr1 KO mouse mPFC.
The etiology of FXS is complex. In the Fmr1 KO mouse mPFC expression of many synaptic receptors and accessory proteins is altered affecting both the intrinsic properties of principal neurons and synaptic signaling (Darnell et al. 2011; Ascano et al. 2012) . However, the changes found in the Fmr1 KO mPFC do not necessarily match those found in other brain regions even in adult mice. Notably compared with the hippocampus contrary changes in potassium channel function have been reported Kalmbach et al. 2015) , with further disagreement over the expression of LTP (Sidorov et al. 2013) . Adding a further incongruity, in the Fmr1 KO hippocampus mGlu 5 mediated LTD is enhanced (Huber et al. 2002) , in contrast to the reduced mGlu 5 LTD observed here in the 2-month-old mPFC. However, the 2 brain regions do expresses fundamentally different forms of LTD. mGlu 5 LTD in the hippocampus requires coordinated protein synthesis from local mRNAs; the loss of FMRP dysregulates this process reducing the threshold of LTD induction. In contrast mPFC mGlu 5 LTD requires 2-AG production and retrograde signaling to the presynapse; prior work has implicated a disconnection between mGlu 5 and DGLα as the likely source of this malfunction in Fmr1 KO mice (Jung et al. 2012 ). Thus it is not so much changes in mGlu 5 function that are important, but rather changes in downstream mGlu 5 coupled signaling. Indeed, compared with many other synaptic channels and receptors, actual changes in mGlu 5 expression are either minor or absent in Fmr1 KO mice (Dölen et al. 2007 ). This refinement of mGlu 5 theory of FXS is in line with current studies that have identified the binding of Homers to mGlu 5 as critically involved the synaptic dysfunctions in FXS (Ronesi et al. 2012; Guo et al. 2015) . Increased mGlu 5 association with short form Homer 1a accounts for many of the signaling abnormalities in the Fmr1 KO mouse, principally through the loss of tight coupling of mGlu 5 to downstream signaling cascades in the perisynaptic annulus. Such a mechanism might account for the loss of eCB-LTD observed here in the mPFC.
Theories of FXS and other neurodevelopmental disorders, notably Down's syndrome and autism, have understandably focused on neuronal changes occurring in early life. However exclusively studying the immature brain can potentially miss important neurophysiological changes that occur in later life. The mouse mPFC in line with the human prefrontal cortex has a delayed maturation compared with other brain regions. Evidence points to early and sustained expression of CB 1 receptors in frontal regions throughout life, however other components of the eCB signaling complex may have a more varied expression profile, including into adulthood (Long et al. 2012) . We observed in 1-year-old Fmr1 KO mice and wildtype littermates a TRPV1 receptor dependence in the induction of eCB-LTD. At this age wildtype mice retained a sensitivity to CB 1 receptor inhibition, but in Fmr1 KO neurons LTD was independent of the CB 1 receptor. The role of TRPV1 receptors in eCB-LTD is becoming increasingly appreciated (Castillo et al. 2012) . Nevertheless, there is a surprising heterogeneity in the TRPV1 contribution to eCB mechanisms of synaptic depression throughout the CNS. In both a subset of excitatory and inhibitory hippocampal synapses TRPV1 receptor mediated mechanisms appear to lend a layer of synaptic specificity to eCB-LTD, resulting in sub-compartment distinct CB 1 receptor and TRPV1 receptor sensitive synapses (Gibson et al. 2008; Chávez et al. 2010 Chávez et al. , 2014 . In contrast at other synapses co-activation of TRPV1 receptors with CB 1 receptors appears to have an important synergistic role leading to co-operative depression of synaptic transmission (Grueter et al. 2010; Puente et al. 2011; Cui et al. 2015) , or in some cases a mutual antagonism of eCB-LTD (Maccarrone et al. 2008; Lee et al. 2015) . Our findings are most consistent with a synergistic role for CB 1 and TRPV1 receptor function at mPFC synapses that naturally develops in the maturing mPFC. Furthermore this maturation of TRPV1 coupled mechanisms does not appear compromised in Fmr1 KO mice resulting in a delayed recovery of mGlu 5 mediated LTD. Whether this recovery of mGlu 5 function at 1 year is correlated to any late onset changes in FXS is unclear, however two recent studies support the idea that mGlu 5 -TRPV1 signaling may be beneficial in FXS. Systemic administration of the FAAH inhibitor URB597 results in an increase in the brain concentrations of the eCB anandamide, a potent TRPV1 agonist coupled to mGlu 5 activity. In Fmr1 KO mice acute treatment with URB597 improves both social and cognitive behavior, suggesting that enhanced anandamide signaling is beneficial (Qin et al. 2015; Wei et al. 2016) . As such it is tempting to speculate that recovered mGlu 5 mediated LTD during senescence may be beneficial.
In contrast to the age-linked recovery of mGlu 5 mediated LTD in the Fmr1 KO mPFC, we recently reported an agelinked loss of LTP in these same neurons (Martin et al. 2016) . At the mPFC synapses NMDA receptor mediated LTP is normal in 2-month-old Fmr1 KO mice, but diminished in 1-yearold. We traced this late onset deficit to loss of synaptic NMDA receptor function. Surprisingly we found that the reduced LTP was tractable to acute mGlu 5 inhibition with MPEP. Although there is no evidence an interaction between these 2 synaptic deficits in the Fmr1 KO mouse, it suggests adulthood onset changes in multiple aspects of mPFC function, which are possibly linked to the complex FXS phenotype. Furthermore, the complicating implication here is that interventions aimed at restoring one form of synaptic plasticity in the Fmr1 KO mPFC, may directly antagonize other forms of synaptic plasticity at the same synapse. We restored eCB-LTD in 2-month-old Fmr1 KO neurons using the MGL inhibitor JZL184. However systemic JZL184 is reported to affect not only on demand 2-AG mediated signaling, but also basal 2-AG levels leading to potentially negative effects (Long et al. 2009 ). An alternative strategy is the use of positive allosteric modulators and we found that enhancement of mGlu 5 signaling with the positive allosteric modulator CDPPB also restored eCB-LTD in these neurons. However such an intervention is unlikely to succeed with concomitant MPEP treatment. Beyond highlighting a need for a more nuanced approach to pharmacotherapy in addressing FXS linked synaptic changes in the mPFC, these observations demonstrate the inherent complexity of FXS. Nevertheless the new inclusion of TRPV1 receptors in the etiology of FXS, coupled with an increasingly better understanding of the underlying synaptic physiology, hopefully promises the development of new therapeutic strategies.
